Myeloma‐Associated Sporadic Late‐Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report
eJHaem · 2026-10 · 7 (5)
DOI: 10.1002/jha2.70390 ↗Kurz gefasst
Fallbericht in der Zeitschrift eJHaem, online erschienen am 15.09.2026. Verfasst von Kenji Moriwaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology Rheumatology and Infectious Diseases Graduate School of Medical Sciences Kumamoto University Kumamoto Japan. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sporadic late‐onset nemaline myopathy (SLONM) is a rare, acquired myopathy often associated with monoclonal gammopathy. We report a 48‐year‐old man presenting with progressive proximal and truncal muscle weakness in whom SLONM associated with smoldering myeloma was highly suspected. He received daratumumab, lenalidomide, and dexamethasone followed by high‐dose melphalan with autologous stem cell transplantation and posttransplant therapy. Treatment resulted in marked improvement in muscle strength and performance status. The patient achieved minimal residual disease negativity and has remained relapse‐free for 5 years. This case highlights the potential efficacy of daratumumab‐based therapy followed by transplantation in SLONM associated with plasma cell dyscrasia. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology Rheumatology and Infectious Diseases Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
- Department of Neurology Graduate School of Medical Sciences Kumamoto University Kumamoto Japan.
Zitieren
APA
Moriwaki, K., Kawano, Y., Nakajima, M., Nishimura, N., Ueda, M., & Yasunaga, J. I. (2026). Myeloma‐Associated Sporadic Late‐Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report. eJHaem, 7(5). https://doi.org/10.1002/jha2.70390
Vancouver
Moriwaki K, Kawano Y, Nakajima M, Nishimura N, Ueda M, Yasunaga JI. Myeloma‐Associated Sporadic Late‐Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report. eJHaem. 2026;7(5). doi:10.1002/jha2.70390
BibTeX
@article{Moriwaki2026,
author = {Moriwaki, Kenji and Kawano, Yawara and Nakajima, Makoto and Nishimura, Nao and Ueda, Mitsuharu and Yasunaga, Jun-Ichirou},
title = {Myeloma‐Associated Sporadic Late‐Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report},
journal = {eJHaem},
year = {2026},
volume = {7},
number = {5},
doi = {10.1002/jha2.70390}
}
EUVIMED